FIELD: medicine. SUBSTANCE: method involves administering combinations having therapeutically effective drug and/or therapeutic preparation for treating pathologic states and diseases and some quantity of hyaluronic acid and/or its salts and/or its homologues, analogs, derivatives, complexes, esters, subunit fragments enough for facilitating medicine transport through tissue, including cicatricial tissue, at a place subjected to treatment, through cellular membranes and separate target cells. EFFECT: enhanced effectiveness of treatment; avoided adverse side effects. 178 cl
